Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-EPCAM, 17-1A Vector   (CAT#: GTVCR-WQ53MR)

This product GTVCR-WQ53MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting EPCAM. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Mus musculus
RefSeq NM_002354.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 4072
UniProt ID P16422
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-EPCAM, 17-1A Vector (GTVCR-WQ53MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1891MR IVTScrip™ pT7-VEE-mRNA-Anti-ITGAV&ITGB3, MEDI-522 Vector Vector MEDI-522
GTVCR-WQ883MR IVTScrip™ pT7-VEE-mRNA-Anti-S, CB-6 Vector Vector CB-6
GTVCR-WQ2064MR IVTScrip™ pT7-VEE-mRNA-Anti-TIGIT, MTIG-7192-A Vector Vector MTIG-7192-A
GTVCR-WQ1185MR IVTScrip™ pSP6-VEE-mRNA-Anti-VEGFA, Fab-12 variant Y0317 Vector Vector Fab-12 variant Y0317
GTVCR-WQ2339MR IVTScrip™ pT7-VEE-mRNA-Anti-GP, REGN-3470-3471-3479 Vector Vector REGN-3470-3471-3479
GTVCR-WQ1410MR IVTScrip™ pSP6-VEE-mRNA-Anti-MS4A1, HS006 Vector Vector HS006
GTVCR-WQ626MR IVTScrip™ pSP6-VEE-mRNA-Anti-MSLN, BAY 2287409 Vector Vector BAY 2287409
GTVCR-WQ1766MR IVTScrip™ pSP6-VEE-mRNA-Anti-PCSK9, LY-3015014 Vector Vector LY-3015014
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.